Cargando…
Systemic Infusion of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Peritoneal Dialysis Patients: Feasibility and Safety
OBJECTIVE: Using mesenchymal stem cells (MSCs) is regarded as a new therapeutic approach for improving fibrotic diseases. the aim of this study to evaluate the feasibility and safety of systemic infusion of autologous adipose tissue-derived MSCs (AD-MSCs) in peritoneal dialysis (PD) patients with ex...
Autores principales: | Alatab, Sudabeh, Shekarchian, Soroosh, Najafi, Iraj, Moghadasali, Reza, Ahmadbeigi, Naser, Pourmand, Mohammad Reza, Bolurieh, Tina, Jaroughi, Neda, Pourmand, Gholamreza, Aghdami, Nasser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099152/ https://www.ncbi.nlm.nih.gov/pubmed/30123994 http://dx.doi.org/10.22074/cellj.2019.5591 |
Ejemplares similares
-
Risk factors of severe peritoneal sclerosis in chronic peritoneal dialysis patients
por: Alatab, Sudabeh, et al.
Publicado: (2016) -
Strategies for Prevention and Treatment of Peritoneal Fibrosis: A Scientometric Study
por: Alatab, Sudabeh, et al.
Publicado: (2019) -
Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients
por: Makhlough, Atieh, et al.
Publicado: (2017) -
Cellular and Molecular Mechanisms of Kidney Development: From the Embryo to the Kidney Organoid
por: Khoshdel Rad, Niloofar, et al.
Publicado: (2020) -
Peritoneal Dialysis as an Alternative Choice for Renal Replacement Therapy in Emergency Department
por: Najafi, Iraj
Publicado: (2014)